Functional decline in patients with and without peripheral arterial disease: Predictive value of annual changes in levels of C-reactive protein and D-dimer

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 4, 2006, Pages 374-379

  McDermott, Mary M ^a,e   Liu, Kiang ^a   Guralnik, Jack M ^b   Ferrucci, Luigi ^b   Green, David ^a   Greenland, Philip ^a   Tian, Lu ^a   Criqui, Michael H ^c   Lo, Carol ^a   Rifai, Nader ^d   Ridker, Paul M ^d   Zheng, Jane ^a   Pearce, William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; D DIMER;

ADULT; AGED; AGING; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CIRCANNUAL RHYTHM; DETERIORATION; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; FEMALE; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TASK PERFORMANCE;

EID: 33645960109     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.4.374     Document Type: Article

References (34)

1. Mitch WE, Goldberg AL. Mechanism of muscle wasting: the role of ubiquitin-proteasome pathway. N Engl J Med. 1996;335:1897-1905.
2. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol. 1991;260:E727-E730.
3. Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med. 1994;205:182-185.
4. Charters Y, Grimble RF. Effect of recombinant human tumor necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats. Biochem J. 1989;258:493-497.
5. Tayek JA. Effects of tumor necrosis factor alpha in skeletal muscle amino acid metabolism studies in-vivo. J Am Coll Nutr. 1996;15:164-168.
6. Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. Acute treatment with tumor necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem. 1993;125:11-18.
7. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol Med Sci. 2002;57A:M326-M32.
8. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-646.
9. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;12:1947-1954.
10. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292:453-461.
11. McDermott MM, Green D, Greenland P, et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol. 2003;92:194-199.
12. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
13. Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. Arterioscler Thromb Vasc Biol. 1999;19:493-498.
14. McDermott MM, Greenland P, Green D, et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation. 2003;107:191-198.
15. McDermott MM, Guralnik JM, Greenland P, et al. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. J Am Geriatr Soc. 2004;52:1888-1894.
16. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837-845.
17. Olin JW. The clinical evaluation and office based detection of peripheral arterial disease. In: Hirsch AT, Olin JW, eds. An office-based approach to the diagnosis and treatment of peripheral arterial disease, I: the epidemiology and practical detection of peripheral arterial disease. Am J Med. Continuing Education Series. 1998;10-17.
18. McDermott MM, Criqui MH, Liu K, et al. The lower ankle brachial index calculated by averaging the dorsalis pedis and posterior tibial arterial pressures is most closely associated with leg functioning in peripheral arterial disease. J Vasc Surg. 2000;32:1164-1171.
19. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995;91:1472-1479.
20. Guralnik JM, Fried LP, Simonsick EM, et al. The Women's Health and Aging Study: health and social characteristics of older women with disability. Bethesda, MD: National Institute on Aging; 1995. NIH publication No. 95-4009, Appendix E.
21. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34:505-514.
22. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum. 1986;29:1039-1049.
23. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The six-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919-923.
24. Montgomery PS, Gardner AW. The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc. 1998;46:706-711.
25. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol Med Sci. 1994;49:M85-M94.
26. Guralnik JM, Ferrucci L, Simonsick E, et al. Lower extremity function in persons over 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
27. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics. 1982;38:963-974.
28. Little RJA. Modeling the drop-out mechanism in repeated-measures studies. J Am Stat Assoc. 1995;90:1112-1121.
29. Fitzmaurice GM, Laird NM, Shneyer L. An alternative parameterization of the general linear mixture model for longitudinal data with nonignorable drop-outs. Stat Med. 2001;20:1009-1021.
30. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med. 1999;340:115-126.
31. Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest. 2002;121:1262-1268.
32. Edgington TS, Curtiss LK, Plow EF. A linkage between the haemostatic and immune systems embodied in the fibrinolytic release of lymphocytic suppressive peptides. J Immunol. 1985;134:471-477.
33. Yanez ND, Kronmal RA, Shemanski LR. The effects of measurement error in response variables and tests of association of explanatory variables in change models. Stat Med. 1998;17:2597-2606.
34. Taaffe DR, Harris TB, Ferrucci L, Row J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur Studies of Successful Aging. J Gerontol Med Sci. 2000;55A:M709-M715.